ArticleBiological psychiatry2019
Augmentation of Exposure Therapy With Cholinergic Blockade: Promising Novel Approach or Too Early to Tell?
Barbara O Rothbaum, Kerry J Ressler
Abstract readComment
In one paragraphArticle in Biological psychiatry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
2 authors.
Barbara O RothbaumDepartment of Psychiatry and Behavioral Sciences, Emory University, Atlanta, Georgia. Electronic address: brothba@emory.edu.
Kerry J ResslerDepartment of Psychiatry, Harvard Medical School, Boston, Massachusetts; Division of Depression and Anxiety, McLean Hospital, Belmont, Massachusetts.
Funding
Longitudinal Assessment of Post-traumatic SyndromesU01MH110925 · NIMH · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KESSLER, RONALD C, KOENEN, KARESTAN C · 2016 to 2020
$25.8MSPARED CenterP50MH115874 · NIMH · MCLEAN HOSPITAL · PI RESSLER, KERRY J. · 2019 to 2023
$13.7MPsychiatric Genomics Consortium for PTSDR01MH106595 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI KARESTAN C KOENEN, Caroline M Nievergelt · 2016 to 2026
$8.4M2 of 2 Prospective Determination of Psychobiological Risk Factors for PTSDR01MH094757 · NIMH · EMORY UNIVERSITY · PI RESSLER, KERRY J. · 2012 to 2016
$2.3M4/7 Psychiatric Genomics Consortium: Advancing Discovery and ImpactR01MH124847 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI NIEVERGELT, CAROLINE M, SEBAT, JONATHAN · 2021 to 2025
$2.1MNeurobiology of Traumatic Dissociation in a Transdiagnostic Study of Women with Childhood MaltreatmentR21MH112956 · NIMH · MCLEAN HOSPITAL · PI KAUFMAN, MILISSA L · 2017 to 2018
$446kNIMH NIH HHS P50 MH115874NIMH NIH HHS R01 MH094757NIMH NIH HHS R01 MH106595NIMH NIH HHS R01 MH124847NIMH NIH HHS R21 MH112956NIMH NIH HHS U01 MH110925
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Implosive TherapyPhobia, SocialCholinergic AgentsHippocampusHumansScopolamineCholinergic AgentsScopolamine
Identifiers
PMID31601363
PMCPMC8072447
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390